Vimarsana
Biggest News Aggregation in the World

Fda Approves News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Approves. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Approves Today - Breaking & Trending Today

FDA Approves New Treatment For Urinary Tract Infections - Vimarsana News

FDA Approves New Treatment For Urinary Tract Infections

The U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus.

FDA Approves Basilea's Zevtera Antibiotic For Three Different Uses; Stock Up - Vimarsana News

FDA Approves Basilea's Zevtera Antibiotic For Three Different Uses; Stock Up

The U.S. Food and Drug Administration has approved Basilea Pharmaceutica International Ltd.'s new Zevtera Antibiotic (ceftobiprole medocaril sodium for injection) for three different bacterial infections.

FDA Approves Invitae's DNA Test To Assess Predisposition For Certain Cancers - Vimarsana News

FDA Approves Invitae's DNA Test To Assess Predisposition For Certain Cancers

The U.S. Food and Drug Administration granted de novo marketing authorization for Invitae's Common Hereditary Cancers Panel, an in vitro diagnostic test to help detect dozens of cancer types.

FDA Approves New Oncology Drug for Clinical Trials - Vimarsana News

FDA Approves New Oncology Drug for Clinical Trials

FDA Approves New Oncology Drug for Clinical Trials

Zurzuvae | FDA approves first postpartum depression pill in the US - Vimarsana News

Zurzuvae | FDA approves first postpartum depression pill in the US

The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.